REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives ; day:29 ; month:4 ; year:2024 ; pages:1-19
Updates in surgery ; (29.4.2024), 1-19
- Creator
-
Boggi, Ugo
Kauffmann, Emanuele F.
Napoli, Niccolò
Barreto, S. George
Besselink, Marc G.
Fusai, Giuseppe K.
Hackert, Thilo
Hilal, Mohammad Abu
Marchegiani, Giovanni
Salvia, Roberto
Shrikhande, Shailesh V.
Truty, Mark
Werner, Jens
Wolfgang, Christopher
Bannone, Elisa
Capretti, Giovanni
Cattelani, Alice
Coppola, Alessandro
Cucchetti, Alessandro
De Sio, Davide
Di Dato, Armando
Di Meo, Giovanna
Fiorillo, Claudio
Gianfaldoni, Cesare
Ginesini, Michael
Hidalgo Salinas, Camila
Lai, Quirino
Miccoli, Mario
Montorsi, Roberto
Pagnanelli, Michele
Poli, Andrea
Ricci, Claudio
Sucameli, Francesco
Tamburrino, Domenico
Viti, Virginia
Cameron, John
Clavien, Pierre-Alain
Asbun, Horacio J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13304-024-01860-0
- URN
-
urn:nbn:de:101:1-2407112122364.519582711983
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boggi, Ugo
- Kauffmann, Emanuele F.
- Napoli, Niccolò
- Barreto, S. George
- Besselink, Marc G.
- Fusai, Giuseppe K.
- Hackert, Thilo
- Hilal, Mohammad Abu
- Marchegiani, Giovanni
- Salvia, Roberto
- Shrikhande, Shailesh V.
- Truty, Mark
- Werner, Jens
- Wolfgang, Christopher
- Bannone, Elisa
- Capretti, Giovanni
- Cattelani, Alice
- Coppola, Alessandro
- Cucchetti, Alessandro
- De Sio, Davide
- Di Dato, Armando
- Di Meo, Giovanna
- Fiorillo, Claudio
- Gianfaldoni, Cesare
- Ginesini, Michael
- Hidalgo Salinas, Camila
- Lai, Quirino
- Miccoli, Mario
- Montorsi, Roberto
- Pagnanelli, Michele
- Poli, Andrea
- Ricci, Claudio
- Sucameli, Francesco
- Tamburrino, Domenico
- Viti, Virginia
- Cameron, John
- Clavien, Pierre-Alain
- Asbun, Horacio J.
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Clinical usefulness of four-dimensional dynamic ventilation CT for borderline resectable locally advanced esophageal cancer
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
Editorial: Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Conference
Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Clinical usefulness of four-dimensional dynamic ventilation CT for borderline resectable locally advanced esophageal cancer
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
Editorial: Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Conference
Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Clinical usefulness of four-dimensional dynamic ventilation CT for borderline resectable locally advanced esophageal cancer
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
Editorial: Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Conference
Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer